Stage FocusSeries A, Series B+
GeographyRest of World
TypeVC
Last Activity2025
Industry Focus
Industries
AIMedtech
Technical BenchLimited
Investor TypeGeneralist
ExposureSome DeepTech Investments
Bio
Norrsken22 was founded by Niklas Adalberth (Klarna co-founder) and Hans Otterling as a $205M growth-stage Africa-focused VC, exceeding the $200M target. The fund is backed by 30+ unicorn founders as LPs and advisors, with roughly $10M average tickets at Series A/B/C.
The allocation splits 50% new investments and 50% follow-on. Focus areas include fintech, edtech, medtech, and market-enabling solu...
Notable Investments
S
Smile IDSimilar Funds
Airtree Ventures
Sydney, Australia
GeneralistAIClimate TechMedtechSeedSeries A
AV
Atlantic Vantage Point
Paris, France
GeneralistAIDefenseMedtechSeries ASeries B+
F
FinRebel
New York, United States
GeneralistAIBlockchainMedtechSeedSeries A
Granite Asia
Singapore
GeneralistAIClimate TechMedtechSeedSeries A
NC
Newfund Capital
Paris, France
GeneralistAINeurotechMedtechPre-SeedSeed
OV
OCA Ventures
Chicago, United States
GeneralistAIMedtechBiotechSeedSeries A